AstraZeneca to launch direct-to-pharmacy delivery model in Poland
This article was originally published in SRA
Executive Summary
AstraZeneca Poland – a member of the AstraZeneca Group – has announced that it will be launching a direct-to-pharmacy (DTP) delivery system in the first half of 2009. The company – which will be the first pharmaceutical firm in Poland that would implement this type of delivery system – has completed tendering procedures, selecting three Polish wholesalers as its logistics operators.
You may also be interested in...
MHRA’s Beneficial EU Relationship And Profitable Synergies With NICE: An Interview With Michael Rawlins
In December, Michael Rawlins was appointed head of the U.K.’s Medicines and Healthcare products Regulatory Agency. He recognizes the MHRA’s mutually beneficial relationship with European counterparts and is looking to safeguard synergies with other national regulatory bodies and NICE.
EMA Acts To Freeze GVK Drugs, Guard Against Shortages
The EMA has recommended suspension of some 700 drug formations linked with Indian clinical trials company GVK Biosciences, but assures national agencies that this won’t result in shortages or safety issues.
EMA Acts To Freeze Drugs Linked to GVK Bio, Guards Against Shortages
EMA has recommended suspension of some 700 drug formations linked with Indian clinical trials company GVK Biosciences, but assures national agencies that this won’t result in shortages or safety issues.